Results 221 to 230 of about 134,214 (298)
An In Vitro Study Simulating Prophylactic Anticoagulation in Haemophilia A and B
ABSTRACT Introduction Patients with haemophilia A (HA) and haemophilia B (HB) are at increased bleeding risk. A recent guidance document suggests considering pharmacological thromboprophylaxis on a case‐by‐case basis in these patients undergoing surgery at high‐risk of venous thromboembolism.
Nicoletta Riva +8 more
wiley +1 more source
Quantifying disease severity in amanitin-intoxicated patients by fusing common laboratory values. [PDF]
Ohland PLS +4 more
europepmc +1 more source
Disulfide bond status links the open and closed conformations of prothrombin
Abstract Emerging evidence indicates that structural changes in proteins can influence autoimmune recognition. Antibodies targeting the central blood coagulation protein, prothrombin, are frequently detected in patients with the autoimmune disorder, antiphospholipid syndrome.
Mark Schreuder +4 more
wiley +1 more source
Prothrombinase processivity is conferred by substrate allostery. [PDF]
Üstok FI +3 more
europepmc +1 more source
Genetic hepatic cholestasis: NGS diagnostic yield. Over a 10‐year period, NGS (gene panel/WES) established a genetic diagnosis in 70% of 66 families with hepatic cholestasis, with a molecular yield of 62%. ABCB11 was the most mutated gene, and PFIC Type 2 was the leading diagnosis, underscoring the critical role of NGS in guiding genetic counseling and
Amal Abdmouleh +12 more
wiley +1 more source
Apixaban Use Before Kidney Transplantation: Is Reversal Necessary? [PDF]
Cotiguala L +11 more
europepmc +1 more source
ABSTRACT Aim To develop a next‐generation, longer‐acting, more‐clinical‐benefits agonist to achieve sustained efficacy with improved tolerability. Methods CT130 was designed from semaglutide. Binding affinity was validated via molecular dynamics and cellular assays.
Wei Ding +4 more
wiley +1 more source
Treatment of Deep Vein Thrombosis in Congenital Factor VII Deficiency: A Case Report and Literature Review. [PDF]
Mortensen SG +4 more
europepmc +1 more source
ABSTRACT Thrombotic events, particularly venous thromboembolism (VTE), are a significant source of morbidity and mortality among patients with hematologic malignancies. These patients face unique challenges due to treatment‐related complications such as thrombocytopenia, coagulopathy, and heightened bleeding risk.
Mario Biglietto +12 more
wiley +1 more source

